BIOACTIVATION OF DIETARY PHENOLS BY HEMOPROTEINS
血蛋白对膳食酚类的生物活性
基本信息
- 批准号:6341884
- 负责人:
- 金额:$ 21.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA damage animal genetic material tag butylated hydroxytoluene carcinogen testing chemical carcinogenesis cytochrome P450 dietary constituent drug metabolism enzyme activity enzyme induction /repression enzyme inhibitors glutathione transferase laboratory mouse lung neoplasms metallothionein mutagen testing mutagens neoplasm /cancer genetics nutrition related tag quinones tissue /cell culture tumor promoters
项目摘要
The long-term goal of this research is to elucidate the underlying
mechanisms by which phenolic compounds present in the human diet influence
tumorigenesis. Ongoing studies demonstrates that the oxidative metabolism
of alkylphenols by cytochromes P450 lead, in many cases, to the formation
of quinoid products capable of covalent binding and/or free radical
generation in cells. We now propose to extend this work to investigate the
involvement of such reactive metabolites in tumor promotion utilizing the
most thoroughly characterized model for probing mechanistic aspects of
promotion in the lung. This system involves the enhancement of lung tumor
development by chronic administration of the food additive butylated
hydroxytoluene (BHT) to carcinogen-initiated mice. It has been
demonstrated that metabolism of BHT in the target organ is necessary for
promotion and it is known that BHT is converted to reactive quinoid
metabolites in lung. These findings lead to the hypothesis that promotion
depends upon two successive P450 catalyzed oxidations to the ultimate
promoting species, a strongly electrophilic quione methide which alkylates
one or more critical proteins leading to a disruption of growth control
mechanisms. The following specific aims are proposed: (1) Determine the
role of metabolism in the differential responsiveness of promotion-
sensitive (B+) and promotion-resistant (B-) mice to the lung tumor
promoter BHT. Conversion of BHT to a quinone methide and other reactive
metabolites, as well as the detoxification of reactive metabolites, will
be examined in lung tissues and cells from B+ and B- mice. (2) Investigate
alkylation targets of a BHT-derived quinone methide in lung cells that
directly or indirectly impair cell-cell signaling. Protein alkylation by
a highly reactive quinone methide metabolite of BHT will be examined in
cells isolated from the lungs of B= and B- mice, and in tumorigenic and
non-tumorigenic cell lines derived from murine lung. Alkylation patterns
will be compared by radiochemical and immunochemical methods and selected
adducts identified by mass spectrometry and microsequencing. (3) Examine
biochemical consequences and oxidative damage in lung cells exposed to
reactive metabolites of BHT. Isolated cells from B+ and B- mice and cell
lines will be treated with reactive quinoid metabolites of BHT to
investigate cytotoxicity, oxidative damage, inhibition of mitochondrial
function, and inhibition of enzymes involved in detoxification.
这项研究的长期目标是阐明基础
人类饮食中存在酚类化合物影响的机制
肿瘤发生。正在进行的研究表明氧化代谢
在许多情况下,细胞色素P450铅通过烷基苯酚的形成
能够共价结合和/或自由基的奎因类产品的
在细胞中产生。我们现在建议扩展这项工作,以调查
这种反应性代谢产物参与利用肿瘤促进
最彻底的特征模型,用于探测机械方面
在肺中促进。该系统涉及增强肺部肿瘤
长期给药食品添加剂丁基的开发
羟基甲苯(BHT)至致癌物引起的小鼠。它一直
证明BHT在目标器官中的代谢是必要的
促进,众所周知,BHT转化为反应性奎因
肺中的代谢产物。这些发现导致了促进的假设
取决于连续的P450催化氧化到最终
促进物种,一种强烈的亲电奎因甲基,烷基化
一种或多种关键蛋白质导致增长控制的破坏
机制。提出了以下特定目标:(1)确定
代谢在促进的差异反应性中的作用 -
敏感(B+)和抗促进性(B-)小鼠对肺肿瘤
发起人BHT。 BHT转换为醌甲基和其他反应性
代谢物以及反应性代谢产物的排毒将
在B+和B小鼠的肺组织和细胞中检查。 (2)调查
BHT衍生的喹酮甲基在肺细胞中的烷基化靶标的
直接或间接损害细胞 - 细胞信号传导。蛋白质烷基化
BHT的高反应性醌代谢物将在
从B =和B-小鼠的肺中分离出来的细胞,在肿瘤中和
源自鼠肺的非肿瘤细胞系。烷基化模式
将通过放射化学和免疫化学方法进行比较,并选择
通过质谱和微链测序确定的加合物。 (3)检查
暴露于肺部细胞的生化后果和氧化损伤
BHT的反应性代谢物。来自B+和B小鼠和细胞的分离细胞
线条将用BHT的反应性喹啉代谢物处理
研究细胞毒性,氧化损伤,抑制线粒体
功能和抑制参与排毒的酶。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN A THOMPSON其他文献
JOHN A THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN A THOMPSON', 18)}}的其他基金
A PHASE I EVALUATION OF THE SAFETY AND PK OF PRO-1 IN STAGE IV MELANOMA PATIENTS
PRO-1 在 IV 期黑色素瘤患者中的安全性和 PK 的 I 期评估
- 批准号:
7379363 - 财政年份:2006
- 资助金额:
$ 21.8万 - 项目类别:
A PHASE I STUDY TO EVALUATE THE SAFETY AND PK OF PRO-1 IN STAGE IV PATIENTS
评估 PRO-1 在 IV 期患者中的安全性和 PK 的 I 期研究
- 批准号:
7198874 - 财政年份:2005
- 资助金额:
$ 21.8万 - 项目类别:
Allo Stem Cell Transplant as Immunotherapy for Melanoma
同种异体干细胞移植作为黑色素瘤的免疫疗法
- 批准号:
6446455 - 财政年份:2001
- 资助金额:
$ 21.8万 - 项目类别:
Allo Stem Cell Transplant as Immunotherapy for Melanoma
同种异体干细胞移植作为黑色素瘤的免疫疗法
- 批准号:
6522680 - 财政年份:2001
- 资助金额:
$ 21.8万 - 项目类别:
ACQUISTION OF AN ELECTROSPRAY TANDEM MASS SPECTROMETER
购买电喷雾串联质谱仪
- 批准号:
2503084 - 财政年份:1998
- 资助金额:
$ 21.8万 - 项目类别:
PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
慢性同种异体肾移植排斥的临床前模型
- 批准号:
2017362 - 财政年份:1997
- 资助金额:
$ 21.8万 - 项目类别:
PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
慢性同种异体肾移植排斥的临床前模型
- 批准号:
2713441 - 财政年份:1997
- 资助金额:
$ 21.8万 - 项目类别:
FORMATION AND REACTIVITY OF TOXIC QUINONE METHIDES
有毒醌甲基化物的形成和反应性
- 批准号:
2155070 - 财政年份:1994
- 资助金额:
$ 21.8万 - 项目类别:
BIOACTIVATION OF DIETARY PHENOLS BY HEMOPROTEINS
血蛋白对膳食酚类的生物活性
- 批准号:
6137434 - 财政年份:1994
- 资助金额:
$ 21.8万 - 项目类别:
Bioactivation of Dietary Phenols by Hemoproteins
血红素蛋白对膳食酚类的生物活化
- 批准号:
6785870 - 财政年份:1994
- 资助金额:
$ 21.8万 - 项目类别:
相似海外基金
Patterns of background nucleotide substitution in the human lineage
人类谱系中背景核苷酸取代的模式
- 批准号:
7077029 - 财政年份:2006
- 资助金额:
$ 21.8万 - 项目类别:
Assessing Mobile Element-based Mutagenic Recombination
评估基于移动元件的诱变重组
- 批准号:
7155693 - 财政年份:2006
- 资助金额:
$ 21.8万 - 项目类别:
Antioxidant Enzymes and Cell Cycle Checkpoint Pathways
抗氧化酶和细胞周期检查点途径
- 批准号:
7102437 - 财政年份:2006
- 资助金额:
$ 21.8万 - 项目类别: